AMGN

David M. Reese

Known title: EVP, Research and DevelopmentCIK: 0001748434

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Amgen Outperforms Market Amid Dow Jones Rotation. Amgen has recently exceeded broader market returns, a trend highlighted in recent analyses of Dow Jones stocks making bullish moves during defensive market rotations. This performance contrasts with peers like Merck, where analysts are comparing dividend growth potential. While the stock shows relative strength, it remains within its 52-week range, with the average analyst target price set significantly above current levels.

this person other insiders at AMGN

Transaction History

AMGN▼ Sell$184K
AMGN▼ Sell$150K
AMGN▲ Buy$0
AMGN▼ Sell$246K
AMGN▼ Sell$227K
AMGN▼ Sell$2.2M
AMGN▲ Buy$0
AMGN▼ Sell$0
AMGN▼ Sell$0
AMGN▲ Buy$0
AMGN▼ Sell$189K
AMGN▼ Sell$199K
AMGN▼ Sell$222K
AMGN▼ Sell$1.1M
AMGN▲ Buy$0
AMGN▼ Sell$7.7M
AMGN▲ Buy$1.4M
AMGN▼ Sell$2.6M
AMGN▲ Buy$0
AMGN▼ Sell$197K
AMGN▼ Sell$180K
AMGN▼ Sell$191K
AMGN▼ Sell$1.7M
AMGN▲ Buy$0
AMGN▼ Sell$0
AMGN▼ Sell$138K
AMGN▼ Sell$193K
AMGN▲ Buy$0
AMGN▼ Sell$160K
AMGN▼ Sell$933K
AMGN▲ Buy$0
AMGN▼ Sell$664K
AMGN▼ Sell$136K
AMGN▼ Sell$178K
AMGN▲ Buy$0
AMGN▼ Sell$46K
AMGN▼ Sell$1.2M
AMGN▲ Buy$0
AMGN▼ Sell$460K

We use analytics to understand how market-wall is used. No personal data is sold.